Skip to main content

Table 3 bNED rate due to various factors

From: Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years

Factors

N (bNED rate, %)

PSA

 

 0-20.0 ng/ml

79 (59/76)

 >20.0 ng/ml

60 (25/42)

 p-value

0.028

Gleason score

 

 <7

77 (53/69)

 ≥7

65 (31/48)

 p-value

0.137

Clinical stage

 

 T1b-T2b

78 (52/67)

 T2c

64 (32/50)

 p-value

0.094

Prostate volume

 

 ≥30 ml

74 (40/54)

 <30 ml

70 (44/63)

 p-value

0.740

PPC

 

 <50%

81 (56/69)

 ≥50%

58 (28/48)

 p-value

0.006

D 90

 

 ≥140 Gy

81 (63/78)

 <140 Gy

52 (17/33)

 p-value

0.009